Long COVID Research & Potential Treatments Part 2 (E28) Ft. Prof David Putrino скачать в хорошем качестве

Long COVID Research & Potential Treatments Part 2 (E28) Ft. Prof David Putrino

This podcast episode features Professor David Putrino, a physiotherapist and neuroscientist, discussing his research on potential treatments for long COVID. Putrino explores clinical trials repurposing HIV antivirals like Maraviroc and Truvada, targeting viral persistence and reactivated latent infections. His team employs a stepwise, experimental approach to identify responders and non-responders through deep phenotyping. This method aims to uncover biomarkers and refine treatments. Putrino also highlights the Cohen Center for Recovery from Complex Chronic Illness, a hybrid clinical and research center fostering collaboration among patients, clinicians, and researchers. The center focuses on accessible care, accepting insurance, and advancing solutions for long COVID. Professor David Putrino is a physiotherapist with a PhD in Neuroscience. He is currently the Director of Rehabilitation Innovation for the Mount Sinai Health System, and a Professor in the Department of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai.  Professor Putrino recently opened the Mount Sinai Cohen Center for Recovery from Complex Chronic Illness in New York also known as (CoRE) and serves as CoRE’s Family Director and is also a member of PolyBio’s Long COVID Research Consortium. Today's episode is the second in a two part series looking at research into potential treatments for Long COVID. Watch Part One:    • Long COVID Research & Potential Treat...   Find out more at https://longcovidtheanswers.com This podcast is CERTIFED CONTINUED PROFESSIONAL DEVELOPMENT CPD/CME. Healthcare Professionals and can earn 0.5 MainPro+ Credits! Please register at https://longcovidtheanswers.com/cpd-r... and watch via the CPD/ CME dashboard area to claim your credits. REFERENCES 1 Polybio Article - A clinical trial of repurposed HIV antivirals in Long COVID 2 Patterson BK, Yogendra R, Guevara-Coto J, Mora-Rodriguez RA, Osgood E, Bream J, Parikh P, Kreimer M, Jeffers D, Rutland C, Kaplan G. Case series: maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC). Frontiers in Medicine. 2023 Feb 8;10:1122529. 3 Polybio Article - Long COVID low-dose rapamycin clinical trial 4 Polybio Article - Lumbrokinase Long COVID & ME/CFS clinical trial